nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP1A2—Dacarbazine—muscle cancer	0.128	0.187	CbGbCtD
Propafenone—ABCB1—Dactinomycin—muscle cancer	0.0968	0.142	CbGbCtD
Propafenone—CYP2C8—Etoposide—muscle cancer	0.0807	0.118	CbGbCtD
Propafenone—CYP1A2—Etoposide—muscle cancer	0.0625	0.0917	CbGbCtD
Propafenone—ABCB1—Vincristine—muscle cancer	0.0596	0.0875	CbGbCtD
Propafenone—ABCB1—Etoposide—muscle cancer	0.0546	0.0802	CbGbCtD
Propafenone—ABCB1—Doxorubicin—muscle cancer	0.0373	0.0547	CbGbCtD
Propafenone—ABCB1—Methotrexate—muscle cancer	0.0361	0.053	CbGbCtD
Propafenone—CYP3A4—Vincristine—muscle cancer	0.0357	0.0524	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—muscle cancer	0.0351	0.0515	CbGbCtD
Propafenone—CYP3A4—Etoposide—muscle cancer	0.0327	0.0481	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—muscle cancer	0.0223	0.0328	CbGbCtD
Propafenone—Carvedilol—VEGFA—muscle cancer	0.00284	0.48	CrCbGaD
Propafenone—Salsalate—PTGS2—muscle cancer	0.00154	0.26	CrCbGaD
Propafenone—Oxaprozin—PTGS2—muscle cancer	0.00154	0.26	CrCbGaD
Propafenone—Pain—Vincristine—muscle cancer	0.000518	0.00165	CcSEcCtD
Propafenone—Constipation—Vincristine—muscle cancer	0.000518	0.00165	CcSEcCtD
Propafenone—Osteoarthritis—Doxorubicin—muscle cancer	0.000518	0.00165	CcSEcCtD
Propafenone—Chest pain—Etoposide—muscle cancer	0.000512	0.00164	CcSEcCtD
Propafenone—Eosinophilia—Methotrexate—muscle cancer	0.000512	0.00163	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000508	0.00162	CcSEcCtD
Propafenone—Pancreatitis—Methotrexate—muscle cancer	0.000507	0.00162	CcSEcCtD
Propafenone—Discomfort—Etoposide—muscle cancer	0.000506	0.00162	CcSEcCtD
Propafenone—Hypersensitivity—Dactinomycin—muscle cancer	0.000499	0.0016	CcSEcCtD
Propafenone—Gastrointestinal pain—Vincristine—muscle cancer	0.000495	0.00158	CcSEcCtD
Propafenone—Confusional state—Etoposide—muscle cancer	0.000495	0.00158	CcSEcCtD
Propafenone—Cardiac arrest—Doxorubicin—muscle cancer	0.000492	0.00157	CcSEcCtD
Propafenone—Infection—Etoposide—muscle cancer	0.000487	0.00156	CcSEcCtD
Propafenone—Ataxia—Doxorubicin—muscle cancer	0.000487	0.00156	CcSEcCtD
Propafenone—Asthenia—Dactinomycin—muscle cancer	0.000486	0.00155	CcSEcCtD
Propafenone—Blood creatinine increased—Doxorubicin—muscle cancer	0.000485	0.00155	CcSEcCtD
Propafenone—Dysuria—Methotrexate—muscle cancer	0.000483	0.00154	CcSEcCtD
Propafenone—Dehydration—Doxorubicin—muscle cancer	0.000482	0.00154	CcSEcCtD
Propafenone—Thrombocytopenia—Etoposide—muscle cancer	0.00048	0.00153	CcSEcCtD
Propafenone—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00048	0.00153	CcSEcCtD
Propafenone—Tachycardia—Etoposide—muscle cancer	0.000479	0.00153	CcSEcCtD
Propafenone—Abdominal pain—Vincristine—muscle cancer	0.000479	0.00153	CcSEcCtD
Propafenone—Body temperature increased—Vincristine—muscle cancer	0.000479	0.00153	CcSEcCtD
Propafenone—Liver function test abnormal—Doxorubicin—muscle cancer	0.000478	0.00153	CcSEcCtD
Propafenone—Skin disorder—Etoposide—muscle cancer	0.000477	0.00152	CcSEcCtD
Propafenone—Erectile dysfunction—Methotrexate—muscle cancer	0.000476	0.00152	CcSEcCtD
Propafenone—Dry skin—Doxorubicin—muscle cancer	0.000475	0.00152	CcSEcCtD
Propafenone—Hyperhidrosis—Etoposide—muscle cancer	0.000474	0.00152	CcSEcCtD
Propafenone—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000473	0.00151	CcSEcCtD
Propafenone—Hypokalaemia—Doxorubicin—muscle cancer	0.000471	0.00151	CcSEcCtD
Propafenone—Breast disorder—Doxorubicin—muscle cancer	0.000468	0.00149	CcSEcCtD
Propafenone—Anorexia—Etoposide—muscle cancer	0.000468	0.00149	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000466	0.00149	CcSEcCtD
Propafenone—Diarrhoea—Dactinomycin—muscle cancer	0.000464	0.00148	CcSEcCtD
Propafenone—Infestation NOS—Methotrexate—muscle cancer	0.000461	0.00147	CcSEcCtD
Propafenone—Infestation—Methotrexate—muscle cancer	0.000461	0.00147	CcSEcCtD
Propafenone—Drowsiness—Methotrexate—muscle cancer	0.000461	0.00147	CcSEcCtD
Propafenone—Depression—Methotrexate—muscle cancer	0.000459	0.00147	CcSEcCtD
Propafenone—Hypotension—Etoposide—muscle cancer	0.000458	0.00146	CcSEcCtD
Propafenone—Gastritis—Doxorubicin—muscle cancer	0.000458	0.00146	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000457	0.00146	CcSEcCtD
Propafenone—Muscular weakness—Doxorubicin—muscle cancer	0.000457	0.00146	CcSEcCtD
Propafenone—Renal failure—Methotrexate—muscle cancer	0.000453	0.00145	CcSEcCtD
Propafenone—Abdominal distension—Doxorubicin—muscle cancer	0.000451	0.00144	CcSEcCtD
Propafenone—Stomatitis—Methotrexate—muscle cancer	0.000449	0.00144	CcSEcCtD
Propafenone—Dysphagia—Doxorubicin—muscle cancer	0.000447	0.00143	CcSEcCtD
Propafenone—Influenza—Doxorubicin—muscle cancer	0.000447	0.00143	CcSEcCtD
Propafenone—Hypersensitivity—Vincristine—muscle cancer	0.000446	0.00143	CcSEcCtD
Propafenone—Eosinophilia—Doxorubicin—muscle cancer	0.000443	0.00142	CcSEcCtD
Propafenone—Paraesthesia—Etoposide—muscle cancer	0.000441	0.00141	CcSEcCtD
Propafenone—Haematuria—Methotrexate—muscle cancer	0.000439	0.0014	CcSEcCtD
Propafenone—Pancreatitis—Doxorubicin—muscle cancer	0.000439	0.0014	CcSEcCtD
Propafenone—Dyspnoea—Etoposide—muscle cancer	0.000437	0.0014	CcSEcCtD
Propafenone—Somnolence—Etoposide—muscle cancer	0.000436	0.00139	CcSEcCtD
Propafenone—Angina pectoris—Doxorubicin—muscle cancer	0.000436	0.00139	CcSEcCtD
Propafenone—Hepatobiliary disease—Methotrexate—muscle cancer	0.000436	0.00139	CcSEcCtD
Propafenone—Epistaxis—Methotrexate—muscle cancer	0.000435	0.00139	CcSEcCtD
Propafenone—Asthenia—Vincristine—muscle cancer	0.000435	0.00139	CcSEcCtD
Propafenone—Vomiting—Dactinomycin—muscle cancer	0.000431	0.00138	CcSEcCtD
Propafenone—Agranulocytosis—Methotrexate—muscle cancer	0.00043	0.00137	CcSEcCtD
Propafenone—Rash—Dactinomycin—muscle cancer	0.000427	0.00137	CcSEcCtD
Propafenone—Decreased appetite—Etoposide—muscle cancer	0.000427	0.00136	CcSEcCtD
Propafenone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000424	0.00135	CcSEcCtD
Propafenone—Fatigue—Etoposide—muscle cancer	0.000423	0.00135	CcSEcCtD
Propafenone—Pain—Etoposide—muscle cancer	0.00042	0.00134	CcSEcCtD
Propafenone—Constipation—Etoposide—muscle cancer	0.00042	0.00134	CcSEcCtD
Propafenone—Dysuria—Doxorubicin—muscle cancer	0.000418	0.00134	CcSEcCtD
Propafenone—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000416	0.00133	CcSEcCtD
Propafenone—Haemoglobin—Methotrexate—muscle cancer	0.000416	0.00133	CcSEcCtD
Propafenone—Diarrhoea—Vincristine—muscle cancer	0.000414	0.00132	CcSEcCtD
Propafenone—Haemorrhage—Methotrexate—muscle cancer	0.000414	0.00132	CcSEcCtD
Propafenone—Hepatitis—Methotrexate—muscle cancer	0.000414	0.00132	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—muscle cancer	0.000413	0.00132	CcSEcCtD
Propafenone—Urinary tract disorder—Methotrexate—muscle cancer	0.000409	0.00131	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—muscle cancer	0.000407	0.0013	CcSEcCtD
Propafenone—Urethral disorder—Methotrexate—muscle cancer	0.000405	0.0013	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—muscle cancer	0.000405	0.00129	CcSEcCtD
Propafenone—Feeling abnormal—Etoposide—muscle cancer	0.000404	0.00129	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—muscle cancer	0.000404	0.00129	CcSEcCtD
Propafenone—Nausea—Dactinomycin—muscle cancer	0.000403	0.00129	CcSEcCtD
Propafenone—Gastrointestinal pain—Etoposide—muscle cancer	0.000401	0.00128	CcSEcCtD
Propafenone—Dizziness—Vincristine—muscle cancer	0.000401	0.00128	CcSEcCtD
Propafenone—Infestation—Doxorubicin—muscle cancer	0.000399	0.00127	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—muscle cancer	0.000399	0.00127	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—muscle cancer	0.000399	0.00127	CcSEcCtD
Propafenone—Visual impairment—Methotrexate—muscle cancer	0.000399	0.00127	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—muscle cancer	0.000392	0.00125	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000391	0.00125	CcSEcCtD
Propafenone—Urticaria—Etoposide—muscle cancer	0.00039	0.00125	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—muscle cancer	0.000389	0.00124	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—muscle cancer	0.000389	0.00124	CcSEcCtD
Propafenone—Abdominal pain—Etoposide—muscle cancer	0.000388	0.00124	CcSEcCtD
Propafenone—Body temperature increased—Etoposide—muscle cancer	0.000388	0.00124	CcSEcCtD
Propafenone—Eye disorder—Methotrexate—muscle cancer	0.000387	0.00124	CcSEcCtD
Propafenone—Tinnitus—Methotrexate—muscle cancer	0.000386	0.00123	CcSEcCtD
Propafenone—Vomiting—Vincristine—muscle cancer	0.000385	0.00123	CcSEcCtD
Propafenone—Cardiac disorder—Methotrexate—muscle cancer	0.000384	0.00123	CcSEcCtD
Propafenone—Rash—Vincristine—muscle cancer	0.000382	0.00122	CcSEcCtD
Propafenone—Dermatitis—Vincristine—muscle cancer	0.000382	0.00122	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—muscle cancer	0.00038	0.00122	CcSEcCtD
Propafenone—Headache—Vincristine—muscle cancer	0.000379	0.00121	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000377	0.00121	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—muscle cancer	0.000376	0.0012	CcSEcCtD
Propafenone—Angiopathy—Methotrexate—muscle cancer	0.000375	0.0012	CcSEcCtD
Propafenone—Immune system disorder—Methotrexate—muscle cancer	0.000374	0.00119	CcSEcCtD
Propafenone—Mediastinal disorder—Methotrexate—muscle cancer	0.000373	0.00119	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—muscle cancer	0.000372	0.00119	CcSEcCtD
Propafenone—Alopecia—Methotrexate—muscle cancer	0.000366	0.00117	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—muscle cancer	0.000365	0.00117	CcSEcCtD
Propafenone—Mental disorder—Methotrexate—muscle cancer	0.000362	0.00116	CcSEcCtD
Propafenone—Hypersensitivity—Etoposide—muscle cancer	0.000361	0.00115	CcSEcCtD
Propafenone—Erythema—Methotrexate—muscle cancer	0.00036	0.00115	CcSEcCtD
Propafenone—Malnutrition—Methotrexate—muscle cancer	0.00036	0.00115	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—muscle cancer	0.00036	0.00115	CcSEcCtD
Propafenone—Nausea—Vincristine—muscle cancer	0.00036	0.00115	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—muscle cancer	0.000359	0.00115	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—muscle cancer	0.000358	0.00114	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—muscle cancer	0.000358	0.00114	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000356	0.00114	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—muscle cancer	0.000354	0.00113	CcSEcCtD
Propafenone—Dysgeusia—Methotrexate—muscle cancer	0.000353	0.00113	CcSEcCtD
Propafenone—Asthenia—Etoposide—muscle cancer	0.000352	0.00112	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—muscle cancer	0.000352	0.00112	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—muscle cancer	0.000351	0.00112	CcSEcCtD
Propafenone—Pruritus—Etoposide—muscle cancer	0.000347	0.00111	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—muscle cancer	0.000345	0.0011	CcSEcCtD
Propafenone—Vision blurred—Methotrexate—muscle cancer	0.000339	0.00108	CcSEcCtD
Propafenone—Diarrhoea—Etoposide—muscle cancer	0.000336	0.00107	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—muscle cancer	0.000335	0.00107	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—muscle cancer	0.000334	0.00107	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—muscle cancer	0.000334	0.00107	CcSEcCtD
Propafenone—Anaemia—Methotrexate—muscle cancer	0.000333	0.00106	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—muscle cancer	0.000332	0.00106	CcSEcCtD
Propafenone—Flushing—Doxorubicin—muscle cancer	0.000332	0.00106	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—muscle cancer	0.000325	0.00104	CcSEcCtD
Propafenone—Malaise—Methotrexate—muscle cancer	0.000325	0.00104	CcSEcCtD
Propafenone—Dizziness—Etoposide—muscle cancer	0.000324	0.00104	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—muscle cancer	0.000324	0.00103	CcSEcCtD
Propafenone—Vertigo—Methotrexate—muscle cancer	0.000324	0.00103	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000323	0.00103	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—muscle cancer	0.000322	0.00103	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—muscle cancer	0.00032	0.00102	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—muscle cancer	0.000317	0.00101	CcSEcCtD
Propafenone—Cough—Methotrexate—muscle cancer	0.000314	0.001	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—muscle cancer	0.000314	0.001	CcSEcCtD
Propafenone—Convulsion—Methotrexate—muscle cancer	0.000312	0.000997	CcSEcCtD
Propafenone—Vomiting—Etoposide—muscle cancer	0.000312	0.000997	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—muscle cancer	0.000312	0.000996	CcSEcCtD
Propafenone—Erythema—Doxorubicin—muscle cancer	0.000312	0.000996	CcSEcCtD
Propafenone—Rash—Etoposide—muscle cancer	0.000309	0.000988	CcSEcCtD
Propafenone—Dermatitis—Etoposide—muscle cancer	0.000309	0.000987	CcSEcCtD
Propafenone—Headache—Etoposide—muscle cancer	0.000307	0.000982	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—muscle cancer	0.000307	0.000982	CcSEcCtD
Propafenone—Chest pain—Methotrexate—muscle cancer	0.000307	0.000979	CcSEcCtD
Propafenone—Myalgia—Methotrexate—muscle cancer	0.000307	0.000979	CcSEcCtD
Propafenone—Tension—Doxorubicin—muscle cancer	0.000306	0.000978	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—muscle cancer	0.000305	0.000976	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000304	0.000973	CcSEcCtD
Propafenone—Discomfort—Methotrexate—muscle cancer	0.000303	0.000968	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—muscle cancer	0.000303	0.000968	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—muscle cancer	0.0003	0.000958	CcSEcCtD
Propafenone—Confusional state—Methotrexate—muscle cancer	0.000296	0.000947	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—muscle cancer	0.000294	0.000939	CcSEcCtD
Propafenone—Infection—Methotrexate—muscle cancer	0.000292	0.000933	CcSEcCtD
Propafenone—Nausea—Etoposide—muscle cancer	0.000291	0.000931	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000289	0.000924	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—muscle cancer	0.000288	0.000921	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—muscle cancer	0.000288	0.000921	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—muscle cancer	0.000288	0.000919	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—muscle cancer	0.000285	0.000912	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—muscle cancer	0.000284	0.000908	CcSEcCtD
Propafenone—Malaise—Doxorubicin—muscle cancer	0.000281	0.000898	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—muscle cancer	0.00028	0.000895	CcSEcCtD
Propafenone—Anorexia—Methotrexate—muscle cancer	0.00028	0.000895	CcSEcCtD
Propafenone—Syncope—Doxorubicin—muscle cancer	0.00028	0.000893	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—muscle cancer	0.000279	0.000892	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—muscle cancer	0.000276	0.00088	CcSEcCtD
Propafenone—Hypotension—Methotrexate—muscle cancer	0.000275	0.000877	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—muscle cancer	0.000274	0.000876	CcSEcCtD
Propafenone—Cough—Doxorubicin—muscle cancer	0.000272	0.000869	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—muscle cancer	0.00027	0.000863	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—muscle cancer	0.000269	0.00086	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000268	0.000855	CcSEcCtD
Propafenone—Insomnia—Methotrexate—muscle cancer	0.000266	0.000849	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—muscle cancer	0.000265	0.000848	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—muscle cancer	0.000265	0.000848	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—muscle cancer	0.000265	0.000845	CcSEcCtD
Propafenone—Paraesthesia—Methotrexate—muscle cancer	0.000264	0.000843	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000264	0.000842	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—muscle cancer	0.000262	0.000838	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—muscle cancer	0.000262	0.000837	CcSEcCtD
Propafenone—Somnolence—Methotrexate—muscle cancer	0.000261	0.000835	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—muscle cancer	0.00026	0.000829	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—muscle cancer	0.000259	0.000827	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—muscle cancer	0.000257	0.00082	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—muscle cancer	0.000255	0.000816	CcSEcCtD
Propafenone—Oedema—Doxorubicin—muscle cancer	0.000254	0.000813	CcSEcCtD
Propafenone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000254	0.000811	CcSEcCtD
Propafenone—Fatigue—Methotrexate—muscle cancer	0.000253	0.00081	CcSEcCtD
Propafenone—Infection—Doxorubicin—muscle cancer	0.000253	0.000808	CcSEcCtD
Propafenone—Pain—Methotrexate—muscle cancer	0.000251	0.000803	CcSEcCtD
Propafenone—Shock—Doxorubicin—muscle cancer	0.00025	0.0008	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—muscle cancer	0.00025	0.000797	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000249	0.000796	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—muscle cancer	0.000248	0.000794	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—muscle cancer	0.000247	0.00079	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000246	0.000786	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—muscle cancer	0.000243	0.000775	CcSEcCtD
Propafenone—Feeling abnormal—Methotrexate—muscle cancer	0.000242	0.000774	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—muscle cancer	0.00024	0.000768	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—muscle cancer	0.000238	0.00076	CcSEcCtD
Propafenone—Urticaria—Methotrexate—muscle cancer	0.000233	0.000746	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—muscle cancer	0.000232	0.000742	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—muscle cancer	0.000232	0.000742	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000232	0.000741	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—muscle cancer	0.00023	0.000735	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—muscle cancer	0.000229	0.00073	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—muscle cancer	0.000227	0.000725	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—muscle cancer	0.000226	0.000723	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—muscle cancer	0.000224	0.000716	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—muscle cancer	0.000221	0.000707	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00022	0.000702	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—muscle cancer	0.000219	0.000701	CcSEcCtD
Propafenone—Constipation—Doxorubicin—muscle cancer	0.000218	0.000695	CcSEcCtD
Propafenone—Pain—Doxorubicin—muscle cancer	0.000218	0.000695	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—muscle cancer	0.000217	0.000692	CcSEcCtD
Propafenone—Asthenia—Methotrexate—muscle cancer	0.000211	0.000674	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—muscle cancer	0.00021	0.00067	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000208	0.000665	CcSEcCtD
Propafenone—Pruritus—Methotrexate—muscle cancer	0.000208	0.000664	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—muscle cancer	0.000202	0.000646	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—muscle cancer	0.000201	0.000643	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—muscle cancer	0.000201	0.000643	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—muscle cancer	0.000201	0.000642	CcSEcCtD
Propafenone—Dizziness—Methotrexate—muscle cancer	0.000194	0.000621	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—muscle cancer	0.000187	0.000599	CcSEcCtD
Propafenone—Vomiting—Methotrexate—muscle cancer	0.000187	0.000597	CcSEcCtD
Propafenone—Rash—Methotrexate—muscle cancer	0.000185	0.000592	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—muscle cancer	0.000185	0.000591	CcSEcCtD
Propafenone—Headache—Methotrexate—muscle cancer	0.000184	0.000588	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—muscle cancer	0.000183	0.000583	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—muscle cancer	0.00018	0.000575	CcSEcCtD
Propafenone—Nausea—Methotrexate—muscle cancer	0.000175	0.000558	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—muscle cancer	0.000174	0.000556	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—muscle cancer	0.000168	0.000538	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—muscle cancer	0.000162	0.000517	CcSEcCtD
Propafenone—Rash—Doxorubicin—muscle cancer	0.00016	0.000513	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—muscle cancer	0.00016	0.000512	CcSEcCtD
Propafenone—Headache—Doxorubicin—muscle cancer	0.000159	0.000509	CcSEcCtD
Propafenone—Nausea—Doxorubicin—muscle cancer	0.000151	0.000483	CcSEcCtD
